Effect of etanercept and lithium chloride on preventing secondary tissue damage in rats with experimental diffuse severe brain injury

European Review for Medical and Pharmacological Sciences

Volumn 18, Issue 1, 2014, Pages 10-27

  Ekici, M A ^a   Uysal, O ^b   Cikriklar, H I ^a   Ozbek Z ^b   Turgut Cosan, D ^b   Baydemir, C ^b   Kazanci, B ^c   Hafizoglu D ^d  

^a BURSA YUKSEK IHTISAS TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

^c UFUK UNIVERSITY   (Turkey)

^d ULUDAG UNIVERSITY   (Turkey)

Author keywords

Etanercept; Lithium chloride; TNF ; Traumatic brain injury

Indexed keywords

ETANERCEPT; GLIAL FIBRILLARY ACIDIC PROTEIN; LITHIUM CHLORIDE; SODIUM CHLORIDE; TAU PROTEIN; TUMOR NECROSIS FACTOR ALPHA; IMMUNOGLOBULIN G; NEUROPROTECTIVE AGENT; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EDEMA; ELISA READER; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; NERVE CELL DEGENERATION; NERVE FIBER DEGENERATION; NICK END LABELING; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; SHAM PROCEDURE; SPRAGUE DAWLEY RAT; TISSUE INJURY; TRAUMATIC BRAIN INJURY; ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; ASTROCYTE; BLOOD; BRAIN; BRAIN INJURIES; DISEASE MODEL; DRUG COMBINATION; DRUG EFFECTS; METABOLISM; NERVE CELL; PATHOLOGY;

ANIMALS; APOPTOSIS; ASTROCYTES; BRAIN; BRAIN INJURIES; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN G; LITHIUM CHLORIDE; MALE; NEURONS; NEUROPROTECTIVE AGENTS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TUMOR NECROSIS FACTOR; TAU PROTEINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84896953262     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. CHIO CC, LIN JW, CHANG M.W., WANG CC, KUO JR, YANG CZ, CHANG CP Therapeutic evaluation of etaner-cept in a model of traumatic brain injury. J Neurochem 2010; 115: 921-929.
2. MYER DJ, GURKOFF GG, LEE S.M., HOVDA DA, SOFRONIEW MV Essential protective roles of reactive astrocytes in traumatic brain injury. Brain 2006; 129: 2761-2772.
3. CHEN G, SHI J, HU Z., HANG C. Inhibitory effect on cerebral inflammatory response following traumatic brain injury in rats: A potential neuroprotective mechanism of N-Acetylcysteine. Mediat Inflamm 2008; Article ID 716458, 8 pages doi: 10.1155/2008/716458.
4. DAS M, MOHAPATRA S, MOHAPATRA SS New perspectives on central and peripheral immune responses to acute traumatic brain injury. J Neuroinflamm 2012; 9: 236.
5. LILIANG PC, LIANG CL, LU K, WANG K.W., WENG HC, HSIEH CH, TSAI YD, CHEN HJ Relationship between injury severity and serum tau protein levels in traumatic brain injured rats. Resuscitation 2010; 81: 1205-1208.
6. CHEN Y, SWANSON RA Astrocytes and brain injury. J Cerebral Blood Flow Met 2003; 23: 137-149.
7. YANG L, JONES NR, BLUMBERGS P.C., HEUVEL CVD, MOORE EJ, MANAVIS J, SARVESTANI G.T., GHABRIE MN. Severity-dependent expression of pro-inflammatory cytokines in traumatic spinal cord injury in the rat. J Clin Neurosci 2005; 12: 276-284.
8. NEHER MD, WECKBACH S, FLIERL M.A., HUBER-LANG MS, STAHEL PF Molecular mechanisms of inflammation and tissue injury after major trauma-is complement the "bad guy"? J Biomed Sci 2011; 18: 90.
9. SCHMIDT OI, INFANGER M, HEYDE C.E., ERTEL W., STAHEL PF The role of neuroinflammation in traumatic brain injury. Eur J Trauma 2004; 30: 135-149.
10. PARK E, BELL JD, BAKER AJ Traumatic brain injury: Can the consequences be stopped? Can Med Assoc J 2008; 178: 1163-1170.
11. YU CH, YHEE JY, KIM J.H., IM KS, KIM NH, JUNG DI, LEE H.C., CHON SK, SUR JH. Pro- and anti-inflammatory cytokine expression and histopathological characteristics in canine brain with traumatic brain injury. J Vet Sci 2011; 12: 299-301.
12. KHAN M, IM YB, SHUNMUGAVEL A, GILG A.G., DHINDSA RK, SINGH AK, SINGH I. Administration of S-nitrosog-lutathione after traumatic brain injury protects the neurovascular unit and reduces secondary injury in a rat model of controlled cortical impact. J Neuroinflamm 2009; 6: 32.
13. SMITH DH, MEANEY DF Axonal damage in traumatic brain injury. Neuroscientist 2000; 6: 483-495.
14. HORTOBAGYI T, AL-SARRAJ S. The significance of diffuse axonal injury: How to diagnose it and what does it tell us? ACNR 2008; 8: 16-18.
15. IRAZUZTA JE, COURTEN-MYERS G, ZEMLAN F.P., BEKKEDAL MYV, ROSSI J. Serum cleaved Tau protein and neu-robehavioral battery of tests as markers of brain injury in experimental bacterial meningitis. Brain Res 2001; 913: 95-105.
16. WUNDERLICH MT, LINS H, SKALEJ M., WALLESCH CW, GOERTLER M. Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke. Clin Neurol Neurosur 2006; 108: 558-563.
17. SRIRAM K, MATHESON JM, BENKOVIC S.A., MILLER DB, LUSTER MI, O'CALLAGHAN JP. Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-in-duced neurotoxicity: Role of TNF-. FASEB J 2006; 20: 670-682.
18. WILLIAMS AJ, WEI HH, DAVE J.R., TORTELLA FC Acute and delayed neuroinflammatory response following experimental penetrating ballistic brain injury in the rat. J Neuroinflamm 2007; 4: 17.
19. HAUSMANN R, RIEB R, FIEGUTH A., BETZ P. Immunohis-tochemical investigations on the course of as-troglial GFAP expression following human brain injury. Int J Legal Med 2000; 113: 70-75.
20. ZUREK J, FEDORA M. The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury. Acta Neurochir (Wien) 2012; 154: 93-103.
21. LIU T, CLARK RK, MCDONNELL P.C., YOUNG PR, WHITE RF, BARONE FC, FEUERSTEIN GZ Tumor necrosis factor-alpha expression in ischemic neurons. Stroke 1994; 25: 1481-1488.
22. GONG C, QIN Z, BETZ A.L., LIU XH, YANG GY Cellular localization of tumor necrosis factor alpha following focal cerebral ischemia in mice. Brain Res 1998; 801: 1-8.
23. CHEN SF, HUNG TH, CHEN C.C., LIN KH, HUANG YN, TSAI HC, WANG JY Lovastatin improves histological and functional outcomes and reduces inflammation after experimental traumatic brain injury. Life Sci 2007; 81: 288-298.
24. KATO K, LIU H, KIKUCHI S.I., MYERS RR, SHUBAYEV VI Immediate anti-tumor necrosis factor-α (etanercept) therapy enhances axonal regeneration after sciatic nerve crush. J Neurosci Res 2010; 88: 360-368.
25. MORELAND LW, BAUMGARTNER SW, SCHIFF M.H., TINDALL EA, FLEISCHMANN RM, WEAVER AL, ETTLINGER R.E., COHEN S., KOOPMAN WJ, MOHLER K, WIDMER MB, BLOSCH CM. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor recep-tor(p75)-Fc fusion protein. N Engl J Med 1997; 337: 141-147.
26. UMEDA N, ITO S, HAYASHI T., GOTO D, MATSUMOTO I, SUMIDA T. A patient with rheumatoid arthritis who had a normal delivery under etanercept treatment. Intern Med 2010; 49: 187-189.
27. LEE EJ, SHIN MK, KIM NI A clinical trial of combination therapy with etanercept and low dose cy-closporine for the treatment of refractory psoriasis. Ann Dermatol 2010; 22: 138-142.
28. GENOVESE T, MAZZON E, CRISAFULLI C., PAOLA RD, MUIA C, BRAMANTI P, CUZZOCREA S. Immunomodulatory effects of etanercept in an experimental model of spinal cord injury. J Pharmacol Exp Ther 2006; 316: 1006-1016.
29. YOUNG W: Review of lithium effects on brain and blood. Cell Transplant 2009; 18: 951-975.
30. SU H, ZHANG W, GUO J., GUO A, YUAN Q, WU W. Lithium enhances the neuronal differentiation of neural progenitor cells in vitro and after transplantation in to the avulsed ventral horn of adult rats through the secretion of brain-derived neurotrophic factor. J Neurochem 2009; 108: 1385-1398.
31. MARMAROU A, FODA MA, BRINK W, CAMPBELL J., KITA H, DEMETRIADOU K. A new model of diffuse brain injury in rats. Part I: Pathophysiology and biomechanics. J Neurosurg 1994; 80: 291-300.
32. CONROY BP, GRAFE MR, JENKINS L.W., VELA AH, LIN CY, DEWITT DS, JOHNSTON WE Histopathologic consequences of hyperglycemic cerebral ischemia during hypothermic cardiopulmonary bypass in pigs. Ann Thorac Surg 2001; 71: 1325-1334.
33. LI F, LIU KF, SILVA M.D., MENG X., GERRIETS T, HELMER KG, FENSTERMACHER J.D., SOTAK CH, FISHER M. Acute postis-chemic renormalization of the apparent diffusion coefficient of water is not associated with reversal of astrocytic swelling and neuronal shrinkage in rats. Am J Neuroradiol 2002; 23: 180-188.
34. LIN HW, BASU A, DRUCKMAN C., CICCHESE M, KRADY JK, LEVISON, SW. Astrogliosis is delayed in type 1 inter-leukin-1 receptor-null mice following a penetrating brain injury. J Neuroinflamm 2006; 3: 15.
35. SHOJO H, KIBAYASHI K. Changes in localization of synaptophysin following fluid percussion injury in the rat brain. Brain Res 2006; 1078: 198-211.
36. KALAYCI M, UNAL MM, GUL S, ACIKGOZ S., KANDEMIR N, HANCI V, EDEBAL I N, AÇIKGÖZ B. Effect of Coen-zyme Q10 on ischemia and neuronal damage in an experimental traumatic brain-injury model in rats. BMC Neuroscience 2011; 12: 75.
37. ANANIADOUA OG, DROSSOS GE, BIBOU K.N., PALATIANOS GM, JOHNSON EO Acute regional neuronal injury following hypothermic circulatory arrest in a porcine model. Interact Cardiov Th 2005; 4: 597-601.
38. ISAKSSON J, HILLERED L, OLSSON Y. Cognitive and histopathological outcome after weight-drop brain injury in the rat: Influence of systemic administration of monoclonal antibodies to ICAM-1. Acta Neuropathol 2001; 102: 246-256.
39. LAFUENTE JV, MITRE B, ARGANDON EG Spatio-temporal distribution of apoptosis and the modulators there of following a cortical microinfarct in rat brain. Neurosci Res 2007; 57: 354-361.
40. YU HM, YUAN TM, GU W.Z., LI JP Expression of glial fibrillary acidic protein in developing rat brain after intrauterine infection. Neuropathology 2004; 24: 136-143.
41. SOFRONIEW MV, VINTERS HV Astrocytes: Biology and pathology. Acta Neuropathol 2010; 119: 7-35.
42. WEIBENBERGER CA, VARRALLYAY C, RASLAN F., KLEINSCHNITZ C, SIREN AL An experimental protocol for mimicking pathomechanisms of traumatic brain injury in mice. Exp Transl Stroke Med 2012; 4: 1.
43. WOICIECHOWSKY C, SCHÖNING B, DIDINGER G.S., STOCKHAMMER F., VOLK HD Brain-IL-1β triggers as-trogliosis through induction of IL-6: Inhibition by propranolol and IL-10. Med Sci Monit 2004; 10: 325-330.
44. SAIRANEN T, CARPEN O, KARJALAINEN-LINDSBERG ML, PAETAU A., TURPEINEN U, KASTE M, LINDSBERG PJ Evolution of cerebral tumor necrosis factor-α production during human ischemic stroke. Stroke 2001; 32: 1750-1758.
45. GENOVESE T, MAZZON E, CRISAFULLI C., ESPOSITO E, DE PAOLA R, MUIA C, DI BELLA P, MELI R, BRAMANTI P, CUZ-ZOCREA S. Combination of dexamethasone and etanercept reduces secondary damage in experimental spinal cord trauma. Neuroscience 2007; 150: 168-181.
46. FIX AS, ROSS JF, STITZEL S.R., SWITZER RC Integrated evaluation of central nervous system lesions: stains for neurons, astrocytes, and microglia reveal the spatial and temporal features of MK-801-induced neuronal necrosis in the rat cerebral cortex. Toxicol Pathol 1996; 24: 291-304.
47. KITA T, LIU L, TANAKA N., KINOSHITA Y. The expression of tumor necrosis factor-α in the rat brain after fluid percussive injury. Int J Legal Med 1997; 110: 305-311.
48. HERRERA DG, MAYSINGER D, ALMAZAN G., FUNNEL R, CUELLO AC Analysis of c-Fos and glial fibrillary acidic protein (GFAP) expression following topical application of potassium chloride (KCl) to the brain surface. Brain Res 1998; 784: 71-81.
49. OSHIMA T, LEE S, SATO A., ODA S, HIRASAWA H, YA-MASHITA T. TNF-α contributes to axonal sprouting and functional recovery following traumatic brain injury. Brain Res 2009; 1290: 102-110.
50. PETTIGREW LC, KINDY MS, SCHEFF S, SPRINGER J.E., KRYSCIO RJ, LI Y, GRASS DS Focal cerebral ischemia in the TNF alpha-transgenic rat. J Neuroinflamm 2008; 5: 47.
51. MAO M, HUA Y, JIANG X., LI L, ZHANG L, MU D. Expression of tumor necrosis factor α and neuronal apoptosis in the developing rat brain after neonatal stroke. Neurosci Lett 2006; 403: 227-232.
52. HANG CH, SHI JX, TIAN J, LI J.S., WU W., YIN HX Effect of systemic LPS injection on cortical NF-κB activity and inflammatory response following traumatic brain injury in rats. Brain Res 2004; 1026: 23-32.
53. CAMPBELL SJ, JIANG Y, DAVIS A.E., FARRANDS R., HOL-BROOK J, LEPPERT D, ANTHONY DC Immunomodulato-ry effects of etanercept in a model of brain injury act through attenuation of the acute-phase response. J Neurochem 2007; 103: 2245-2255.
54. TWEEDIE D, SAMBAMURTI K, GREIG NH TNF-alpha inhibition as a treatment strategy for neurodegener-ative disorders: New drug candidates and targets. Curr Alzheimer Res 2007; 4: 378-385.
55. LOPEZ NE, KRZYZANIAK MJ, BLOW C, PUTNAM J., ORTIZ-POMALES Y, HAGENY AM, ELICEIRI B, COIMBRA R., BANSAL V. Ghrelin prevents disruption of the blood-brain barrier after traumatic brain injury. J Neurotrauma 2012; 29: 385-393.
56. LOPEZ NE, KRZYZANIAK MJ, COSTANTINI T.W., PUTNAM J., HAGENY AM, ELICEIRI B, COIMBRA R, BANSAL V. Vagal nerve stimulation decreases blood-brain barrier disruption after traumatic brain injury. J Trauma Acute Care Surg 2012; 72: 1562-1566.
57. SHLOSBERG D, BENIFLA M, KAUFER D., FRIEDMAN A. Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat Rev Neurol 2010; 6: 393-403.
58. MARCHAND F, TSANTOULAS C, SINGH D., GRIST J, CLARK AK, BRADBURY E.J., MAHON SB. Effects of etanercept and minocycline in a rat model of spinal cord injury. Eur J Pain 2009; 13: 673-681.
59. WONG YW, TAM S, SO K.F., CHEN JYH, CHENG WS, LUK KDK, TANG SW, YOUNG W. A three-month, open-label, single-arm trial evaluating the safety and pharmacokinetics of oral lithium in patients with chronic spinal cord injury. Spinal Cord 2011; 49: 94-98.